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INTRODUCTION
Hirsutism is androgen dependent hair growth while 
hypertrichosis refers to hair growth which is not 
androgen dependent.1 Androgens play a pivotal role in 
the growth and maintenance of a hair follicle. Dark-
haired individuals tend to be more hirsute than blonde 
or fair individuals.2 Food and Drug Administration 
(FDA) approves long pulsed diode (810nm) and Nd-YAG 
(1064nm) for hair removal and both of them are suitable 
for darker skin types.3 This study is thus conducted to 
evaluate and compare the efficacy of long pulsed Nd-
YAG laser among patients with biochemically elevated 
androgens versus normal androgen level individuals.
METHODS
This is a prospective analytical study conducted in 
the department of dermatology, Dhulikhel Hospital 
Kathmandu University Hospital, Dhulikhel, Nepal. 
Prior consent was taken from the Institutional Review 
Committee for the initiation of the study. We studied 
a total of 60 female patients, 30 each having elevated 
hormones and normal hormones. Written informed 
consent was obtained from every patient before the 
start of study.  Evaluation was done for facial hair 
removal from November 2010 to November 2011. Age 
of patients ranged from 14-50 years (mean age 27.9 ± 
9.6 years). All patients had Fitzpatrick skin types III, IV 
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and V and hair was terminal and black colored. Detailed 
history was taken including menstrual irregularity, 
fertility profile, diabetes and family history. Patient’s 
height and weight was taken and Body Mass Index (BMI) 
was calculated. Patients with BMI of more than 24.9 Kg/
m2 were considered to be obese. Hormonal panel test 
was done first among all patients in the department of 
clinical biochemistry.  It included Luteinizing Hormone 
(LH), Follicle Stimulating Hormone (FSH), Testosterone, 
Dehydroepiandrosterone Sulphate (DHEA-S), Sex 
Hormone Binding Globulin (SHBG), C-peptide, Thyroid 
Stimulating Hormone (TSH) and C-peptide. C-peptide 
was measured as a marker of insulin resistance as 
its half-life is quite longer than that of insulin and is 
relatively easy to quantify. ELISA technique was used 
to evaluate all hormones using ELISLAW, RFCL and 
diagnostic automation, USA reagents. 
Their values were compared and patients were 
categorized among two groups depending upon androgen 
level and ratio. Group A (n=30) had high androgen (total 
testosterone and dehydroepiandrosterone sulfate) or 
elevated LH: FSH ratio consistent with PCOS and group B 
(n=30) who had normal hormone level. LH: FSH ratio of 
more than 2:1 was considered abnormal. Every patient 
underwent abdomino-pelvic ultrasound to meet the 
diagnosis of PCOS using Rotterdam’s Criteria and adrenal 
tumor was ruled out among all.1 After shaving the 
concerned part all patients received 1064nm longpulse 
Nd-YAG laser with 50 J/cm2 energy and 50 msec pulse 
duration. Laser therapy was repeated every four weeks 
and number of settings was noted for substantial hair 
reduction. More than 50% reduction in hair count was 
considered a success. Efficacy of laser was evaluated on 
the basis of serial hair count. Microsoft Excel was used 
for data entry and SPSS version 16 was used for data 
analysis. Using mean settings required, student’s t-test 
was applied and results were compared. Satisfaction 
of patient was also evaluated as patient satisfaction 
score on a four point Likert scale which included: poor, 
satisfactory, good and excellent.
RESULTS
Age group 15-25 years was the most common age group 
(53%) presenting for hair removal. Likewise age group 
26-35 years had 18% and 36-50 years had 29% patients. 
69% patients were obese (BMI>25) and 37% patients 
had positive family history of hirsutism/hypertrichosis. 
None of the female patients had features of virilization. 
Abnormal TSH was seen among 5 (3 hypothyroid and 2 
hyperthyroidism) patients. C-peptide was high among 9 
patients and all of them belonged to group A (28.1%).
Among group A patients, mean number (mean ±S.D.) of 
treatment sessions required for substantial hair reduction 
was 8.1±1.28, whereas, average 5.7±1.01 sessions 
produced similar results in group B patients (Table 1). 
This finding was found to be statistically significant 
(p-value <0.05). The result of patient satisfaction 
score was illustrated using Likert scale (Figure 1). 
The most common treated site was face-upper lip 
(67.7%). All the complications were transient and mild 
hyperpigmentation was the most frequent complication 
(5%). There was an improvement of hirsutism in a PCOS 
patient following long pulse Nd: Yag laser (Figure 2).
Table 1. Number of settings (with mean setting 






Group A (n=30) 8.1 1.28 < 0.05
Group B (n=30) 5.7 1.01
Figure 1. Patient satisfaction score for hair removal.
Figure 2. Hirsutism of a PCOS patient before and 
after long pulse Nd: YAG laser.
Abbreviations and Symbols
PCOS: Polycystic Ovarian Syndrome
Nd: YAG: Neodymium-Doped Yttrium Aluminum Garnet 
LH: Luteinizing Hormone
FSH: Follicle Stimulating Hormone
TSH: Thyroid Stimulating Hormone 
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DISCUSSION
Prevalence of hirsutism is around 15% among general 
population.4 PCOS is considered to be the commonest 
cause of hirsutism. Apart from androgen disorder 
hirsutism may be a normal variant of hair growth. 
Race and ethnicity also play a major role in body hair 
distribution. Unwanted hair may be distressing. Many 
methods have been used in the past with varying results 
but most of them are temporary and are associated with 
pain, pigmentation, irritation, and distortion of hair 
follicles or scarring. Electrolysis and thermolysis offers 
permanent hair removal but both are impractical for 
larger areas.7 Lasers offer easy advancements of hair 
removal with minimal adverse effects.
Hair may be vellus or terminal.8 Pubertal androgens and 
hair follicle’s intrinsic characteristics determines the 
quality of hair. Hairs of eyebrows, eyelashes and vellus 
hair are androgen insensitive. Excess androgen in ladies 
causes hair growth except in the scalp, where hair loss 
occurs because androgens here shorten the period of 
anagen phase. Ovaries, adrenal glands and peripheral 
fats are the sites of androgens in our body. Androgen 
particularly testosterone is converted into potent 
Dihydrotesosterone (DHT) by type 1-5α-reductase in 
the pilosebaceous unit, which enhances androgen 
receptor binding and exerts end-organ effects.9 Insulin 
has also shown relationship with androgen to regulate 
pilosebaceous unit development.
Hirsutism is the most common cutaneous manifestation 
of PCOS (65-73%) and usually has high testosterone 
level.2,4-6 Idiopathic hirsutism on the other hand 
has normal testosterone level. Acne, seborrhea, 
androgenic alopecia and acanthosis nigricans are other 
dermatological signs of PCOS.
Wavelength ranging from 630 to 1100 nm can irradiate 
hair follicles of anagen phase.10,11 Within this range 
problems are faced with lower wavelength lasers while 
treating darker individuals because in these melanin in 
the epidermis competes as a chromophore for the laser 
light. Also, there is high incidence of epidermal side 
effects in darker individuals. The absorption spectrum 
of melanin ranges from 250–1200 nm and the absorption 
decreases as wavelength increases. Longer wavelength 
lasers penetrate 5 to 7 mm in dermis thus causing less 
epidermal absorption and sufficient follicle injury. 
Hence, Long pulsed diode and Nd-YAG are best used in 
darker skin types. Though diode lasers are considered 
more efficacious than Nd-YAG, Nd-YAG lasers are 
considered safer in treating darker skin types.10,11 This 
is because the longer wavelength of Nd-YAG minimizes 
epidermal melanin absorption and maximizes wavelength 
penetration to the dermal hair follicular unit. Also 
studies recommend multiple treatment sessions rather 
than a single setting. Lorenz S. et al. followed patients 
for one year treated with multiple sessions with long 
pulsed Nd-YAG laser and concluded that greater than 
50% hair reduction remained in patients treated with 
five treatment sessions.12 Mittal R et. al. conducted 
similar study on our skin type and concluded that 56% 
patients were successful to achieve fine vellus hair after 
six treatment sessions.3 
C peptide is a known marker of insulin resistance and 
is also used to monitor its progress.13 Insulin resistance 
is a known feature of PCOS, which stimulates ovarian 
androgen secretion and suppresses SHBG production, 
thus increasing free testosterone level.14,15 Studies 
have shown to have significantly high C peptide among 
patients with hirsutism.16 This was also seen in our study 
where 28.1% of patients had high c peptide level. Among 
ladies diagnosed PCOS, 10% develop diabetes mellitus in 
the third or fourth decade, 40% have impaired glucose 
tolerance and 40% are obese.17 Also studies have shown 
that PCOS and hirsutism are associated with insulin 
resistance independent of obesity.18 
Saleh et al, conducted a similar study to this study where 
after comparing hormonal parameters efficacy of hair 
removal was compared between diode (800nm), ruby 
(694nm) and long pulsed alexandrite (755nm) lasers.19 
They found no significant statistical difference between 
patients with or without hormonal disturbance, PCOS, 
family history or antiandrogen therapy during treatment 
sessions. These results contrasts our findings which might 
be because of the fact that the former study only included 
beard area for the study and the longer wavelength of 
Nd-YAG laser might have produced significant result in 
our study. The former study also concluded that age is an 
important factor to enhance the efficacy of laser. They 
found that patients less than 30 years responded better 
than those more than 30 years regardless of associated 
clinical factors or type of laser used.
Limited sample size and limited studies of this nature 
were the major limitations of our study which demands 
a similar study with ample number of cases. Hence we 
recommend having a hormonal profile test in patients 
with hirsutism before the start of therapy. Patients with 
hormonal parameters indicating PCOS are expected to 
have higher treatment sessions with long pulsed Nd-YAG 
laser.
CONCLUSIONS
Patients with high androgen level or elevated LH: FSH 
ratio requires higher number of setting for unwanted 
hair removal using long pulse Nd-YAG laser as compared 
to patients with normal hormone level. Also, long pulse 
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Nd-YAG laser is efficacious in removing hair in skin types 
III, IV and V.
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